Akzo Nobel India Q1 Review - Improving Trajectory; That's Important In A Turnaround: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Akzo Nobel India Ltd. has continued to report improving volume/revenue trajectory with every passing quarter which underlines the thesis that the turnaround is truly on track.
We believe lower flammable limit growth in Q1 FY22 was one of the highest among peers.
Our structural positive stance on Akzo Nobel is intact, as-
it has strengthened product portfolio via multiple differentiated launches in past two years. It has introduced India’s first bio-based premium interior emulsion in August 2021,
expanded distribution network to 19,000 plus outlets and 14,000 tinting machines and
also focused on brand building initiatives such as Dulux Assurance.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.